Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Apr 10, 2026

MetroCity Bankshares (MCBS): +10.5% Gain in 30 Days Amid Strong Fundamentals and Analyst Support

Key Takeaways

  • MCBS stock rose approximately +10.5% over the past 30 days, driven by positive analyst price target increases and resilient regional banking sector sentiment.
  • Over the past quarter, the stock gained around +15.3%, supported by strong full-year 2025 earnings and consistent dividend declarations.
  • Key factors include analyst upgrades from Keefe, Bruyette & Woods, leadership stability with an interim CFO appointment, and broader market trends favoring community banks.
  • Upcoming Q1 2026 earnings on April 17 represent a critical catalyst for future price movement.
  • Steady loan growth and deposit expansion highlighted in recent financials bolstered investor confidence.

Understanding MetroCity Bankshares (MCBS) and Its Market Position

MetroCity Bankshares, Inc. (MCBS) serves as the holding company for Metro City Bank, a Georgia-based bank established in 2006 and based in Doraville. It offers a variety of commercial banking services, such as checking and savings accounts, certificates of deposit (CDs), diverse loan options including commercial real estate and small business administration loans, treasury management, and online/mobile banking. In the regional banks space within financial services, MCBS targets underserved markets, especially immigrant and small business communities across the Southeast U.S.

From what I see, the company's approach centers on relationship banking, leveraging low-cost deposits and diversified lending to sustain a robust net interest margin (NIM). This strategy has enabled MCBS to hold steady through interest rate shifts, which accounts for its recent edge over broader bank indices via reliable profitability and solid capital levels.

MCBS Stock Performance: Breaking Down the Last 30 Days and Quarter

In the past 30 days, MCBS shares moved up from a closing price of about $28.17 to around $31.14, delivering a +10.5% gain. The advance felt methodical, with the stock surpassing the 50-day moving average at $28.88, indicating growing momentum without sharp swings.

Looking at the quarter, the stock rose roughly +15.3% from about $27.01, demonstrating durability in a uneven environment for regional banks. It started range-bound but built steadily higher, backed by solid fundamentals and growing analyst focus.

Key Drivers Behind MCBS's 30-Day Price Surge

A mix of company news and sector dynamics fueled MCBS's recent 30-day climb. On April 9, Keefe, Bruyette & Woods kept its Market Perform rating but lifted the price target from $32 to $33, showing faith in the bank's path and sparking buyer interest. This followed their March 23 adjustment from $31 to $32, which also lifted spirits.

One thing that stands out is the smooth leadership transition, with Farid Tan named Interim CFO on March 26 in what appeared to be standard changes, avoiding any disruption. Broader tailwinds like steadying interest rates and rising loan demand helped too, as regional players like MCBS gained from favorable inflation and jobs data.

I also checked this using Tickeron’s AI Screener to gauge how MCBS stacks up against peers in the sector.

What Powered MCBS's +15.3% Quarterly Performance

The quarter's +15.3% rise rested on strong Q4 2025 results released January 30, featuring $18.3 million in net income and full-year revenue of $155.9 million, a 10.8% increase from the prior year. Even with a modest EPS shortfall ($0.68 against $0.73 expected), revenue topped forecasts, and a healthy NIM underscored efficiency.

A $0.25 per share quarterly cash dividend announced January 21 further supported investors, offering a yield of about 3.2%. Institutional ownership held firm, with short interest low at 1.4%. Positive industry shifts, like potential regulatory relief and Southeast growth, enhanced these strengths, offsetting prior book value strains from elevated rates.

Trending AI Robots

In my trading routine, I often turn to Tickeron’s Trending AI Robots to spot top performers among hundreds of AI-driven bots scanning thousands of tickers. These bots apply strategies like trend-following, mean reversion, and momentum across short-term, swing, and long-term horizons. I appreciate the clear metrics on win rates, average returns, and Sharpe ratios, which help match bots to my approach. Updated live, the page flags recent standouts tied to market conditions. It's a practical way to add AI automation to my analysis and decisions—worth exploring if you're considering automated tools.

What's Next for MCBS: Key Forecast Drivers to Watch

I'm watching the Q1 2026 earnings on April 17 closely, with expected EPS of $0.70-$0.77 and revenue near $50 million—pay particular attention to NIM and loan growth details. Fed rate moves and regional economic reports could shift views. Keep an eye on deposit growth and possible M&A too. On the risk side, watch credit quality or policy shifts, while upsides might come from more analyst notes or dividend tweaks. This is important because these elements could dictate MCBS's trajectory in the near term.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: MCBS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MCBS's Stochastic Oscillator entering oversold zone

The Stochastic Oscillator for MCBS moved into oversold territory on August 25, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MCBS advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

MCBS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MCBS as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MCBS turned negative on August 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

MCBS moved below its 50-day moving average on August 25, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MCBS entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MCBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.781) is normal, around the industry mean (1.352). P/E Ratio (12.198) is within average values for comparable stocks, (24.338). MCBS's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.825). Dividend Yield (0.031) settles around the average of (0.031) among similar stocks. P/S Ratio (5.391) is also within normal values, averaging (3.769).

Notable companies

The most notable companies in this group are PNC Financial Services Group (NYSE:PNC), US Bancorp (NYSE:USB), Itau Unibanco Banco Holding SA (NYSE:ITUB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Huntington Bancshares (NASDAQ:HBAN), Banco Bradesco SA (NYSE:BBD), Regions Financial Corp (NYSE:RF), KeyCorp (NYSE:KEY).

Industry description

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

Market Cap

The average market capitalization across the Regional Banks Industry is 6.37B. The market cap for tickers in the group ranges from 10.73K to 142.82B. CIHHF holds the highest valuation in this group at 142.82B. The lowest valued company is ACBCQ at 10.73K.

High and low price notable news

The average weekly price growth across all stocks in the Regional Banks Industry was 0%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 14%. SUPV experienced the highest price growth at 14%, while OPHC experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Regional Banks Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was 24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 54
Price Growth Rating: 48
SMR Rating: 52
Profit Risk Rating: 55
Seasonality Score: -28 (-100 ... +100)
View a ticker or compare two or three
MCBS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a holding company which engages in banking and financial solutions

Industry RegionalBanks

Profile
Details
Industry
N/A
Address
5114 Buford Highway
Phone
+1 770 455-4989
Employees
317
Web
https://www.metrocitybank.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.